Rankings
▼
Calendar
MDGL FY 2015 Earnings — Madrigal Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
MDGL
Madrigal Pharmaceuticals, Inc.
$10B
FY 2015 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$3M
Net Income
-$7M
EPS (Diluted)
$-401.56
Cash Flow
Operating Cash Flow
-$71M
Free Cash Flow
-$72M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$68M
Total Liabilities
$18M
Stockholders' Equity
$50M
Cash & Equivalents
$35M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
-$673,000
+100.0%
Operating Income
-$3M
-$84M
+96.2%
Net Income
-$7M
-$86M
+92.1%
← FY 2014
All Quarters
Q1 2016 →